Sirio Pharma Co., Ltd. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €509.96M +17.6% €39.37M +15.7% 7.7% -0.0013 pp €118.57M +16.9% 23.3% -0.0014 pp
    €433.78M +42.9% €34.03M +32.4% 7.8% -0.0062 pp €101.46M +13.4% 23.4% -0.061 pp
    €303.63M +5.8% €25.71M -8.4% 8.5% -0.013 pp €89.44M -14.7% 29.5% -0.071 pp
    €286.88M +14.6% €28.08M -9.9% 9.8% -0.027 pp €104.88M +59.6% 36.6% +0.10 pp
    €250.29M +30.8% €31.17M +80.6% 12.5% +0.034 pp €65.72M +36.2% 26.3% +0.010 pp
    €191.29M -1.0% €17.26M -29.9% 9.0% -0.037 pp €48.26M -5.7% 25.2% -0.013 pp
    €193.20M +19.9% €24.61M +94.8% 12.7% +0.049 pp €51.20M +102.1% 26.5% +0.11 pp
    €161.12M +69.2% €12.63M -85.2% 7.8% -0.82 pp €25.33M -916.7% 15.7% +0.19 pp
    €95.21M -4.6% €85.22M +1,150.7% 89.5% +0.83 pp -€3.10M -109.6% -3.3% -0.36 pp
    €99.84M +5.9% €6.81M -8.4% 6.8% -0.011 pp €32.35M +67.2% 32.4% +0.12 pp
    €94.29M +11.4% €7.44M +12.7% 7.9% +0.00085 pp €19.35M -13.5% 20.5% -0.059 pp
    €84.61M +26.2% €6.61M +20.3% 7.8% -0.0038 pp €22.36M +82.8% 26.4% +0.082 pp
    €67.06M €5.49M 8.2% €12.23M 18.2%

    Notifications